The POU1F1-derived tumors have 499 exclusive proteins that participate in events such as Platinum drug resistance (AKT3, BCL2 and GSTT2) and Prostate cancer (FGFR1, IGF1R and PDGFD) among others. This evidence concerns the gene FGFR1 and prostate cancer.